Effect of Avena sativa L. in treatment of allergic rhinitis

Phase 2

Recruiting

• Conditions: allergic rhinitis.; Allergic rhinitis due to pollen; J30.1

• Registration Number: IRCT20110310006026N12
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 38

Inclusion Criteria

People aged 18 to 65 years
With a diagnosis of allergic rhinitis

Exclusion Criteria

Pregnancy
Nasal polyps
Corticosteroid use in the past 4 weeks
Antihistamine use in the past one week
Having underlying medical conditions especially autoimmune and celiac diseases
Allergy to 2nd generation antihistamines and oats

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The number of eosinophils in nasal smears. Timepoint: Before beginning the treatment and at the end of the second week of treatment. Method of measurement: Counting the number of eosinophils in nasal smears.;Symptoms of allergic rhinitis. Timepoint: Before beginning the treatment and at the end of the second week of treatment. Method of measurement: Recording symptoms of allergic rhinitis by asking the patients.